Class Action Lawsuit Filed Against Outlook Therapeutics, Inc. (OTLK) on Behalf of Investors – Nationally Ranked Investors’ Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

ATLANTA, Nov. 06, 2023 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed against Outlook Therapeutics, Inc. (“Outlook Therapeutics” or “the Company”) (NASDAQ: OTLK). The lawsuit alleges Outlook Therapeutics made false or misleading statements and/or omitted material adverse information regarding the Company’s business, operations, and prospects, including: (i) there was a lack of substantial evidence supporting ONS-5010 as a treatment for wet AMD; (ii) the Company and/or its manufacturing partner had deficient chemistry manufacturing and controls (“CMC”) and other manufacturing issues for ONS-5010, which remained unresolved at the time the ONS-5010 BLA was resubmitted to the FDA; (iii) as a result of all the foregoing, the FDA was unlikely to approve the ONS-5010 BLA in its present form; and (iv) accordingly, ONS-5010’s regulatory and commercial prospects were overstated.

If you bought Outlook Therapeutics shares between December 29, 2022 and August 29, 2023, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/outlook-therapeutics/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is January 2, 2024.

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021 and 2022, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.  

CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
cholzer@holzerlaw.com